Amendment and Mail Process Complete

ISOQ

THIRD PARTY VALIDATION & VERIFICATION LLC

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88297625 FILING DATE 02/12/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE SERVICE MARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY HUSSAIN, TASNEEM
L.O. ASSIGNED O30-NOT FOUND

PUB INFORMATION

RUN DATE 03/28/2020
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 03/27/2020
LITERAL MARK ELEMENT ISOQ

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT ISOQ
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 11-SUBSEQUENT OWNER BEFORE PUBLICATION
NAME THIRD PARTY VALIDATION & VERIFICATION LLC
ADDRESS 7000 BROADWAY, SUITE 307
DENVER, CO 80221
ENTITY 16-LTD LIAB CO
CITIZENSHIP Colorado
DBA/AKA DBA ELLIPSE ANALYTICS

GOODS AND SERVICES

INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug research and development

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 042 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
03/27/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 013
03/27/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 012
03/26/2020 ALIE A ASSIGNED TO LIE 011
03/19/2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 010
09/19/2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 009
09/19/2019 GNRT F NON-FINAL ACTION E-MAILED 008
09/19/2019 CNRT R NON-FINAL ACTION WRITTEN 007
09/16/2019 DOCK D ASSIGNED TO EXAMINER 006
04/03/2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP 005
03/21/2019 DOCK D ASSIGNED TO EXAMINER 004
03/21/2019 DOCK D ASSIGNED TO EXAMINER 003
03/06/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
02/15/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Clinton J. Cusick
CORRESPONDENCE ADDRESS Clinton J. Cusick
CUSICK IP, PLLC
716 N. BETHLEHEM PIKE, SUITE 302
AMBLER PA 19002
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME CBD CliniLabs LLC
ADDRESS 7000 Broadway, Suite 307
Denver, CO 80221
ENTITY 16-LTD LIAB CO
CITIZENSHIP Colorado

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed